Literature DB >> 14526877

Achieving equity in referrals for renal transplant evaluations with African-American patients: the role of nephrology social workers.

William A Wolfe1.   

Abstract

Research over the last 12 years has repeatedly shown that African-American ESRD patients are less likely than white patients to be referred for a transplant evaluation. This article takes an exploratory look at issues surrounding this racial disparity. Among the issues focused on are: (a) the multiple ramifications from this racial disparity; (b) neglected factors which may be militating against the equitable referral of African-American patients; and (c) the vulnerabilities of this patient population. The final focus is on intervention strategies for nephrology social workers and how they might help to facilitate a greater equity in this area of health care with African-American patients.

Entities:  

Mesh:

Year:  2003        PMID: 14526877     DOI: 10.1300/J010v37n03_05

Source DB:  PubMed          Journal:  Soc Work Health Care        ISSN: 0098-1389


  4 in total

1.  African American kidney transplantation survival: the ability of immunosuppression to balance the inherent pre- and post-transplant risk factors.

Authors:  Gregory E Malat; Christine Culkin; Aniruddha Palya; Karthik Ranganna; Mysore S Anil Kumar
Journal:  Drugs       Date:  2009-10-22       Impact factor: 9.546

2.  Trends in kidney transplantation rates and disparities.

Authors:  Kelly L Stolzmann; Leonelo E Bautista; Ronald E Gangnon; Jane A McElroy; Bryan N Becker; Patrick L Remington
Journal:  J Natl Med Assoc       Date:  2007-08       Impact factor: 1.798

3.  Inequalities and outcomes: end stage kidney disease in ethnic minorities.

Authors:  Emma Wilkinson; Alison Brettle; Muhammad Waqar; Gurch Randhawa
Journal:  BMC Nephrol       Date:  2019-06-26       Impact factor: 2.388

4.  The Full Spectrum of Clinical Ethical Issues in Kidney Failure. Findings of a Systematic Qualitative Review.

Authors:  Hannes Kahrass; Daniel Strech; Marcel Mertz
Journal:  PLoS One       Date:  2016-03-03       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.